Value of GCET1, HGAL (GCET2), and LMO2 in the Determination of Germinal Center Phenotype in Diffuse Large B-cell Lymphoma
Objective: Diffuse large B-cell lymphoma (DLBCL) is a biologically heterogeneous disease that is classified into germinal center B-cell (GCB) and non-GCB subtypes, which are prognostically different. The Hans algorithm is the most widely used tool based on CD10, BCL6, and MUM1 expression, but some c...
Main Authors: | Neslihan Berker, Yasemin Özlük, Gulcin Yegen, İbrahim Öner Doğan |
---|---|
Format: | Article |
Language: | English |
Published: |
Galenos Publishing House
2023-08-01
|
Series: | Turkish Journal of Hematology |
Subjects: | |
Online Access: | https://jag.journalagent.com/z4/download_fulltext.asp?pdir=tjh&un=TJH-22844 |
Similar Items
-
A combination of LMO2 negative and CD38 positive is useful for the diagnosis of Burkitt lymphoma
by: Yifei Liu, et al.
Published: (2019-09-01) -
Diagnostic utility of LMO2 immunohistochemistry in distinguishing T-lymphoblastic leukemia/lymphoma from thymoma
by: Divya Bansal, et al.
Published: (2024-01-01) -
Clinical Interest of LMO2 Testing for the Diagnosis of Aggressive Large B-Cell Lymphomas
by: Ivonne Vazquez, et al.
Published: (2020-04-01) -
Expression of Lmo2 in Prostate Carcinoma and Adjacent Prostatic Parenchyma
by: Božo Krušlin, et al.
Published: (2018-01-01) -
LMO1 Gene Polymorphisms Reduce Neuroblastoma Risk in Eastern Chinese Children: A Three-Center Case-Control Study
by: Lili He, et al.
Published: (2018-10-01)